IonicRF
Device Neuromodulation
PDI 05415067029317
General payments
$109,023
Research payments
$185,630
Through program year 2024, $109,023 in general payments and $185,630 in research payments were reported against IonicRF (Neuromodulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $8,816 | 306 |
| 2023 | General | $6,263 | 242 |
| 2023 | Research | $33,471 | 19 |
| 2022 | General | $93,876 | 315 |
| 2022 | Research | $151,804 | 41 |
| 2021 | General | $68 | 5 |
| 2021 | Research | $355 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
868 general · 63 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.